Eosinophilic granuloma of the skull: A retrospective analysis

Pediatric Neurosurgery

Volumn 43, Issue 2, 2007, Pages 97-101

  Park, Seong Hyun ^a   Park, Jaechan ^a   Hwang, Jeong Hyun ^a   Hwang, Sung Kyoo ^a   Hamm, In Suk ^a   Park, Yeun Mook ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

Eosinophilic granuloma; Histiocytosis; Langerhans' cell; Skull

Indexed keywords

INDOMETACIN; METHOTREXATE; PREDNISOLONE; STEROID; VINBLASTINE;

ADJUVANT THERAPY; ARTICLE; BONE LESION; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER THERAPY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; EOSINOPHILIC GRANULOMA; FEMALE; HISTIOCYTOSIS; HUMAN; LANGERHANS CELL; MALE; MULTIPLE CANCER; OUTCOME ASSESSMENT; PATHOLOGY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SKULL TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; BONE DISEASES; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EOSINOPHILIC GRANULOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDOMETHACIN; MAGNETIC RESONANCE IMAGING; MALE; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; RECURRENCE; RETROSPECTIVE STUDIES; SKULL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33847338464     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098380     Document Type: Article

References (20)

1. Bae JK, Kwon CY, Eun JP, et al: Monostotic eosinophilic granuloma of the skull. a case report. J Korean Neurosurg 1997;26:730-734.
2. Bernstrand C, Sandstedt B, Ahstrom L, et al: Long-terum follow-up of Langerhans cell histiocytosis: 39 years' experience at a single centre. Acta Paediatr 2005;94:1073-1084.
3. Broadvent V, Egeler RM, Nesbit ME: Langerhans cell histiocytosis: clinical and epidemiological aspects. Br J Cancer 1994;70:S11-S16.
4. Hand A Jr: Polyuria and tuberculosis. Arch Pediatr 1893;10:673-675.
5. Writing Group of the Histiocyte Society: Histiocytosis syndromes in children. Lancet 1987;i:208-209.
6. Broadbent V, Gadner H, Komp DM, Ladisch S: Histiocytosis syndromes in children. II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Clinical Writing Group of the Histiocyte Society. Med Pediatr Oncol 1989;17:492-495.
7. Nezelof C, Basset F, Rousseau MF: Histiocytosis X: histiogenic arguments for a Langerhans' cell origin. Biomedicine 1973;18:365-371.
8. Favara BE, Feller AC, Pauli M, et al: Contemporary classification of histiocytic disorders. Med Pediatr Oncol 1997;29:157-166.
9. Rawlings CE III, Wilkins RH: Solitary eosinophilic granuloma of the skull. Neurosurgery 1984;15:155-161.
10. Di Nardo LJ, Wetmore RF: Head and neck manifestations of histiocytosis-X in children. Laryngoscope 1989;99:721-724.
11. Titgemeyer C, Grois N, Minkov M, et al: Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-Study. Med Pediatr Oncol 2001;37:108-114.
12. Jubran RF, Marachelian A, Dorey F, et al: Predictors of outcome in children with Langerhans cell histiocytosis. Pediatr Blood Cancer 2005;45:37-42.
13. Stockschlaeder M, Sucker C: Adult Langerhans cell histiocytosis. Eur J Haematol 2006;17:1-6.
14. Fadeel B, Henter JI: Langerhans cell histiocytosis: neoplasia or unbridled inflammation? Trends Immunol 2003;24:409-410.
15. McLean TW, Pritchard J: Langerhans cell histiocytosis and hypercalcemia: clinical response to indomethacin. J Pediatr Hematol Oncol 1996;18:318-320.
16. Munn SE, Olliver L, Broadbent V, et al: Use of indomethacin in Langerhans cell histiocytosis. Med Pediatr Oncol 1999;32:247-249.
17. Ben Ezra JM, Koo CH: Langerhans' cell histiocytosis and malignancies of the M-PRE system. Am J Clin Pathol 1993;99:464-471.
18. Bartholdy N, Thommesen P: Histocytosis X: VII. Prognostic significance of skull lesions. Acta Radiol Oncol 1983;22:125-127.
19. Longaker MA, Frieden IJ, LeBoit PE, et al: Congenital 'self-healing' Langerhans cell histiocytosis: the need for long-term followup. J Am Acad Dermatol 1994;31:910-916.
20. Calming U, Henter JI: Elevated ESR and thrombocytosis may be valuable markers of active disease in Langerhans cell histiocytosis. Acta Paediatr 1998;87:1085-1087.